[
  {
    "ts": null,
    "headline": "Tracking Terry Smith's Fundsmith 13F Portfolio - Q1 2025 Update",
    "summary": "Tracking Terry Smith's Fundsmith 13F Portfolio - Q1 2025 Update",
    "url": "https://finnhub.io/api/news?id=a1fd3663dd9437c15f4f0e731c68ffcfa0c874c6a7695eaf106a72b54c8304e4",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748470189,
      "headline": "Tracking Terry Smith's Fundsmith 13F Portfolio - Q1 2025 Update",
      "id": 134779149,
      "image": "",
      "related": "IDXX",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=a1fd3663dd9437c15f4f0e731c68ffcfa0c874c6a7695eaf106a72b54c8304e4"
    }
  },
  {
    "ts": null,
    "headline": "Transcript : IDEXX Laboratories, Inc. Presents at Stifel Jaws & Paws Conference 2025, May-28-2025 10",
    "summary": "Presenter SpeechJohn Ravis Next up, we have IDEXX Laboratories, the worldwide leader in animal health diagnostics. And joining me on the stage is the company's relatively new CFO, Andrew Emerson....",
    "url": "https://finnhub.io/api/news?id=2bf21fb726deb52c68dab10fec45adb906c39b9b91feb79474485b38ac6b7241",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748445617,
      "headline": "Transcript : IDEXX Laboratories, Inc. Presents at Stifel Jaws & Paws Conference 2025, May-28-2025 10",
      "id": 134757104,
      "image": "",
      "related": "IDXX",
      "source": "Finnhub",
      "summary": "Presenter SpeechJohn Ravis Next up, we have IDEXX Laboratories, the worldwide leader in animal health diagnostics. And joining me on the stage is the company's relatively new CFO, Andrew Emerson....",
      "url": "https://finnhub.io/api/news?id=2bf21fb726deb52c68dab10fec45adb906c39b9b91feb79474485b38ac6b7241"
    }
  },
  {
    "ts": null,
    "headline": "Baird Mid Cap Growth Equity Fund Q1 2025 Commentary",
    "summary": "For the quarter, the Baird Mid Cap Growth portfolio produced a negative return of -9.6%, net of fees, trailing the Russell Midcap Growth decline of -7.1%.",
    "url": "https://finnhub.io/api/news?id=5e4a11b0adb2b458975af40c59d959ff57f432534eafe2ade26fda9c5dea465e",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748419200,
      "headline": "Baird Mid Cap Growth Equity Fund Q1 2025 Commentary",
      "id": 134740799,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1972341389/image_1972341389.jpg?io=getty-c-w1536",
      "related": "IDXX",
      "source": "SeekingAlpha",
      "summary": "For the quarter, the Baird Mid Cap Growth portfolio produced a negative return of -9.6%, net of fees, trailing the Russell Midcap Growth decline of -7.1%.",
      "url": "https://finnhub.io/api/news?id=5e4a11b0adb2b458975af40c59d959ff57f432534eafe2ade26fda9c5dea465e"
    }
  }
]